FHLC Among Health Care ETFs
End-of-day Nov 18, 2026 · 39 Health care ETFs by 1M
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.0% | −4.3% | +0.2% | +3.7% | +17.5% | +20.5% | +52.3% | +39.5% | +209.3% | +316.0% |
| Peer average | −0.9% | −5.3% | −1.4% | −2.4% | +17.0% | +21.8% | +68.8% | +23.4% | +169.9% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$147 of every $1,000 in FHLC is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 14.67% | $1,467.16 | 421K | $595.4M |
| 2 | JNJJohnson & Johnson | Healthcare | 8.69% | $868.64 | 1.3M | $352.5M |
| 3 | ABBVAbbvie | Healthcare | 6.70% | $669.85 | 928K | $271.8M |
| 4 | MRKMerck & NEW | Healthcare | 4.58% | $458.47 | 1.3M | $186.1M |
| 5 | UNHUnitedhealth Group | Healthcare | 4.58% | $458.20 | 477K | $185.9M |
| 6 | TMOThermo Fisher Scientific | Healthcare | 3.30% | $330.46 | 195K | $134.1M |
| 7 | AMGNAmgen | Healthcare | 3.20% | $320.00 | 284K | $129.9M |
| 8 | GILDGilead Sciences | Healthcare | 2.74% | $273.70 | 652K | $111.1M |
| 9 | ABTAbbott Laboratories | Healthcare | 2.36% | $236.15 | 915K | $95.8M |
| 10 | PFEPfizer | Healthcare | 2.10% | $210.09 | 3.0M | $85.3M |
| 11 | ISRGIntuitive Surgical | Healthcare | 1.97% | $197.42 | 186K | $80.1M |
| 12 | DHRDanaher | Healthcare | 1.86% | $186.20 | 335K | $75.6M |
| 13 | VRTXVertex Pharmaceuticals | Healthcare | 1.76% | $175.56 | 133K | $71.2M |
| 14 | 0Y6X.LMedtronic | Healthcare | 1.70% | $169.58 | 673K | $68.8M |
| 15 | MCKMckesson | Healthcare | 1.66% | $165.50 | 62K | $67.2M |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 14.67% |
| 2 | JNJ | Johnson & Johnson | 8.69% |
| 3 | ABBV | Abbvie | 6.70% |
| 4 | MRK | Merck & NEW | 4.58% |
| 5 | UNH | Unitedhealth Group | 4.58% |
| 6 | TMO | Thermo Fisher Scientific | 3.30% |
| 7 | AMGN | Amgen | 3.20% |
| 8 | GILD | Gilead Sciences | 2.74% |
| 9 | ABT | Abbott Laboratories | 2.36% |
| 10 | PFE | Pfizer | 2.10% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 18, 2026 | Sep 22, 2026 | $0.25 |
| Jun 18, 2026 | Jun 23, 2026 | $0.26 |
| Mar 20, 2026 | Mar 24, 2026 | $0.23 |
| Dec 19, 2025 | Dec 23, 2025 | $0.27 |
| Sep 19, 2025 | Sep 23, 2025 | $0.26 |
| Jun 20, 2025 | Jun 24, 2025 | $0.26 |
| Mar 21, 2025 | Mar 25, 2025 | $0.25 |
| Dec 20, 2024 | Dec 24, 2024 | $0.26 |
| Sep 20, 2024 | Sep 24, 2024 | $0.25 |
| Jun 21, 2024 | Jun 25, 2024 | $0.24 |
| Mar 15, 2024 | Mar 20, 2024 | $0.24 |
| Dec 15, 2023 | Dec 20, 2023 | $0.22 |